InhibRx Competitors and Similar CompaniesClear all
InhibRx's competitors and similar companies include Arvelle Therapeutics, Secura Bio, Keros Therapeutics and Dyne Therapeutics.
 InhibRx InhibRx is a clinical-stage biotechnology company developing a broad pipeline of novel biologic therapeutic candidates. |  Secura Bio Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. |  Dyne Therapeutics Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases. | ||
Founding Date | Founding Date 2017 | Founding Date 2019 | Founding Date 2019 | Founding Date 2015 | Founding Date 2018 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Zug, CH HQ Zug, CH | Locations Las Vegas, US HQ San Diego, US | Locations Lexington, US HQ South Wharf, AU | Locations Waltham, US HQ |
Employees | Employees 1531% increase | Employees 10 | Employees 489% increase | Employees 7854% decrease | Employees 1451% decrease |
Valuation ($) | Valuation ($) 233.1 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.3 b | Valuation ($) 3.1 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $244.1m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($241.4m) (FY, 2023) | Net income N/A | Net income N/A | Net income $87m (FY, 2025) | Net income ($446.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 43.6m | Total funding raised $ 180m | Total funding raised $ 195m | Total funding raised $ 90m | Total funding raised $ 165m |
For sources of this data, please see the company profile
View Company Profiles
Secura Bio
HQ
Las Vegas, US
Employees
48↑ 9% increase
Secura Bio is an integrated biopharmaceutical company dedicated to the commercialization of oncology therapies.
View companyKeros Therapeutics
HQ
Lexington, US
Employees
78
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View companyDyne Therapeutics
HQ
Waltham, US
Employees
145↓ 1% decrease
Dyne Therapeutics is a biotechnology company which is engaged in the development of targeted therapies for patients with serious muscle diseases.
View company